141 related articles for article (PubMed ID: 16556703)
1. Rituximab in refractory Wegener's granulomatosis: Favorable or not?
Aries PM; Lamprecht P; Gross WL
Am J Respir Crit Care Med; 2006 Apr; 173(7):815-6; author reply 816. PubMed ID: 16556703
[No Abstract] [Full Text] [Related]
2. Sustained 3-year remission after rituximab treatment in a patient with refractory Wegener's granulomatosis.
Tektonidou MG; Skopouli FN
Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S103. PubMed ID: 16859607
[No Abstract] [Full Text] [Related]
3. Refractory Wegener's granulomatosis: effect of rituximab on granulomatous bilateral orbital involvement.
Avshovich N; Boulman N; Slobodin G; Zeina AR; Rosner I; Rozenbaum M
Isr Med Assoc J; 2009 Sep; 11(9):566-8. PubMed ID: 19960854
[No Abstract] [Full Text] [Related]
4. Rituximab is an alternative in a case of contra-indication of cyclophosphamide in Wegener's granulomatosis.
Bachmeyer C; Cadranel JF; Demontis R
Nephrol Dial Transplant; 2005 Jun; 20(6):1274. PubMed ID: 15840659
[No Abstract] [Full Text] [Related]
5. Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener's granulomatosis: a case report.
Ooka S; Maeda A; Ito H; Omata M; Yamada H; Ozaki S
Mod Rheumatol; 2009; 19(1):80-3. PubMed ID: 18806927
[TBL] [Abstract][Full Text] [Related]
6. [Successful treatment with rituximab in a refractory Wegener's granulomatosis with hypertrophic pachymeningitis and the right orbital granuloma].
Matsudaira R; Tamura N; Nawata M; Kaneda K; Takasaki Y
Nihon Naika Gakkai Zasshi; 2007 Jul; 96(7):1464-6. PubMed ID: 17682433
[No Abstract] [Full Text] [Related]
7. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial.
Keogh KA; Ytterberg SR; Fervenza FC; Carlson KA; Schroeder DR; Specks U
Am J Respir Crit Care Med; 2006 Jan; 173(2):180-7. PubMed ID: 16224107
[TBL] [Abstract][Full Text] [Related]
8. Rituximab as a new therapeutic option in granulomatosis with polyangiitis: a report of two cases.
Dalkilic E; Alkis N; Kamali S
Mod Rheumatol; 2012 Jun; 22(3):463-6. PubMed ID: 21847703
[TBL] [Abstract][Full Text] [Related]
9. [Successful treatment of a patient with refractory Wegener's granulomatosis by rituximab].
Minami R; Miyamura T; Watanabe H; Takahama S; Yamamoto M; Suematsu E
Nihon Rinsho Meneki Gakkai Kaishi; 2007 Apr; 30(2):133-8. PubMed ID: 17473516
[TBL] [Abstract][Full Text] [Related]
10. Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients.
Brihaye B; Aouba A; Pagnoux C; Cohen P; Lacassin F; Guillevin L
Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S23-7. PubMed ID: 17428359
[TBL] [Abstract][Full Text] [Related]
11. Refractory Wegener's granulomatosis presenting with alveolar haemorrhage, treated with rituximab.
Caetano J; Fernandes das Neves M; Oliveira S; Delgado Alves J
BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25519869
[No Abstract] [Full Text] [Related]
12. Two cases of refractory Wegener's granulomatosis successfully treated with rituximab.
Tamura N; Matsudaira R; Hirashima M; Ikeda M; Tajima M; Nawata M; Morimoto S; Kaneda K; Kobayashi S; Hashimoto H; Takasaki Y
Intern Med; 2007; 46(7):409-14. PubMed ID: 17409608
[TBL] [Abstract][Full Text] [Related]
13. Infliximab or rituximab for refractory Wegener's granulomatosis: long-term follow up. A prospective randomised multicentre study on 17 patients.
de Menthon M; Cohen P; Pagnoux C; Buchler M; Sibilia J; Détrée F; Gayraud M; Khellaf M; Penalba C; Legallicier B; Mouthon L; Guillevin L
Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S63-71. PubMed ID: 21586199
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of ANCA-associated vascularitides].
Guillevin L; Pagnoux C
Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
[TBL] [Abstract][Full Text] [Related]
15. Rituximab with or without a conventional maintenance agent in the treatment of relapsing granulomatosis with polyangiitis (Wegener's): a retrospective single-center study.
Azar L; Springer J; Langford CA; Hoffman GS
Arthritis Rheumatol; 2014 Oct; 66(10):2862-70. PubMed ID: 24943239
[TBL] [Abstract][Full Text] [Related]
16. Rituximab as an effective and probably safe treatment for granulomatosis with polyangiitis (Wegener's Granulomatosis).
Tavakolpour S; Alesaeidi S
Int Immunopharmacol; 2019 May; 70():67-68. PubMed ID: 30785092
[No Abstract] [Full Text] [Related]
17. Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations.
Aries PM; Hellmich B; Voswinkel J; Both M; Nölle B; Holl-Ulrich K; Lamprecht P; Gross WL
Ann Rheum Dis; 2006 Jul; 65(7):853-8. PubMed ID: 16269425
[TBL] [Abstract][Full Text] [Related]
18. Refractory pituitary granulomatosis with polyangiitis (Wegener's) treated with rituximab.
Hughes J; Barkhoudarian G; Ciarlini P; Laws ER; Mody E; Inzucchi SE; Woodmansee WW
Endocr Pract; 2013; 19(1):e1-7. PubMed ID: 23186961
[TBL] [Abstract][Full Text] [Related]
19. Rituximab reversed cardiac involvement of Wegener's granulomatosis: magnetic resonance imaging assessment.
Brihaye B; Aouba A; Pagnoux C; Vignaux O; Le Hello C; Guillevin L
Presse Med; 2008 Mar; 37(3 Pt 1):412-5. PubMed ID: 18276102
[TBL] [Abstract][Full Text] [Related]
20. Rituximab for severe refractory pediatric Wegener granulomatosis.
Patel AM; Lehman TJ
J Clin Rheumatol; 2008 Oct; 14(5):278-80. PubMed ID: 18824926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
